Experience

Agios Pharmaceuticals

• United States
• Pharmaceutical Manufacturing
• 300 - 400 Employee

• Vice President, Corporate Development

  • Mar 2023 - Present

• Sr. Director, Corporate Development and Strategy

  • Oct 2019 - Mar 2023



Biogen

• United States
• Biotechnology Research
• 700 & Above Employee

• Disease Area Lead, Early & External Product Commercialization

  • Jun 2018 - Oct 2019

  • Lead team responsible for Commercial strategy for Biogen’s early pipeline in multiple sclerosis, ophthalmology and immunology • Responsible for foundational commercial strategy for pipeline assets, business development commercial assessments (M&A/licensing), disease area strategies and collaboration strategy in supported therapeutic areas

• Director, Global Strategic Forecasting

  • Oct 2015 - Oct 2019

  Lead team of 4 direct reports responsible for all of Biogen’s in-line and late stage product forecasting, in markets including Multiple Sclerosis, Alzheimers’ Disease and Spinal Muscular Atrophy - Delivered strategic analyses for global brand teams and executive customers in support of $M to $B business decisions (e.g., global brand strategy, deals, corporate strategy, LCM) - Led annual long range forecasting / planning and associated executive discussions for Global Commercial… Show more Lead team of 4 direct reports responsible for all of Biogen’s in-line and late stage product forecasting, in markets including Multiple Sclerosis, Alzheimers’ Disease and Spinal Muscular Atrophy - Delivered strategic analyses for global brand teams and executive customers in support of $M to $B business decisions (e.g., global brand strategy, deals, corporate strategy, LCM) - Led annual long range forecasting / planning and associated executive discussions for Global Commercial organization - Built Center of Excellence to support top line forecasting (patients, units) across Regions (US, EU, ROW) and Therapeutic Areas, providing perspective on performance and drivers and playing integral role in financial forecasting cycle - Executed ongoing S&OP process in the US, EU and EM to align demand forecasts with supply plans ensuring smooth operations despite dramatic sales growth - Led early pilot on big data/analytics as foundation for a broader Commercial capability focused on insight generation, revenue generating opportunity identification and decision making

• Associate Director, Strategic Forecasting Lead for Multiple Sclerosis

  • May 2013 - Oct 2015

  -- Forecasting lead on for Global Asset and Strategy teams within Multiple Sclerosis (MS), Biogen’s largest business area -- Accountable for Biogen’s long-term MS patient flow model, a core tool for strategic insights and decision making, long-term planning and M&A opportunity assessments -- Commercial forecasting lead on the Company's Long Range Plan (LRP) and key contributor to other major forecast cycles -- Led initiatives including M&A diligence assessments, Board of Directors… Show more -- Forecasting lead on for Global Asset and Strategy teams within Multiple Sclerosis (MS), Biogen’s largest business area -- Accountable for Biogen’s long-term MS patient flow model, a core tool for strategic insights and decision making, long-term planning and M&A opportunity assessments -- Commercial forecasting lead on the Company's Long Range Plan (LRP) and key contributor to other major forecast cycles -- Led initiatives including M&A diligence assessments, Board of Directors Commercial updates, Life Cycle Management assessments , next-generation asset evaluations, etc.



Strategy&

• United States
• Business Consulting and Services
• 700 & Above Employee

• Engagement Manager

  • Feb 2010 - May 2013

  Strategy, operations and marketing consulting for biopharma and health insurance clients. Led a range of diverse projects including: launch planning, operational improvement, post merger integration, patient journey, segmentation, innovation strategy, organizational/cultural improvement. Strategy, operations and marketing consulting for biopharma and health insurance clients. Led a range of diverse projects including: launch planning, operational improvement, post merger integration, patient journey, segmentation, innovation strategy, organizational/cultural improvement.



L.E.K. Consulting

• United States
• Business Consulting and Services
• 700 & Above Employee

• Consultant

  • 2007 - 2010

  Led commercial assessments across a wide range of biopharmaceutical markets primarily in support of corporate strategy, business development and strategic partnership decisions. Led commercial assessments across a wide range of biopharmaceutical markets primarily in support of corporate strategy, business development and strategic partnership decisions.



Barr Laboratories

• Woodcliff Lake, NJ

• Financial & business development analyst

  • Aug 2003 - Jul 2005

  Finance lead supporting business development and high priority strategic projects for leading generic pharmaceuticals company. Finance lead supporting business development and high priority strategic projects for leading generic pharmaceuticals company.



Bank of America

• United States
• Banking
• 700 & Above Employee

• Healthcare Investment Banking Analyst

  • Sep 2001 - Jul 2003